Cargando…
Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women
Although female dysfunctional voiding (DV) is common in urological practice, it is difficult to treat. This study evaluated the therapeutic efficacy of urethral botulinum toxin A (BoNT-A) on non-neurogenic female DV. Based on the videourodynamic study (VUDS), the DV was classified into three subgrou...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159094/ https://www.ncbi.nlm.nih.gov/pubmed/34069448 http://dx.doi.org/10.3390/toxins13050362 |
_version_ | 1783700008240939008 |
---|---|
author | Jiang, Yuan-Hong Lee, Cheng-Ling Chen, Sheng-Fu Kuo, Hann-Chorng |
author_facet | Jiang, Yuan-Hong Lee, Cheng-Ling Chen, Sheng-Fu Kuo, Hann-Chorng |
author_sort | Jiang, Yuan-Hong |
collection | PubMed |
description | Although female dysfunctional voiding (DV) is common in urological practice, it is difficult to treat. This study evaluated the therapeutic efficacy of urethral botulinum toxin A (BoNT-A) on non-neurogenic female DV. Based on the videourodynamic study (VUDS), the DV was classified into three subgroups according to the obstructive site. A successful treatment outcome was defined as an improvement of voiding efficiency by 10% and reported global response assessment by ≥1. The study compared therapeutic efficacy, baseline urodynamic parameters, and changes in urodynamic parameters between the treatment success and failure groups and among three DV subgroups. Predictive factors for successful treatment were also investigated. A total of 81 women with DV were categorized into three groups: 55 (67.9%) had mid-urethral DV, 19 (23.5%) had distal urethral DV, and 7 (8.6%) had combined BN dysfunction and mid-urethral DV after BN transurethral incision. The treatment outcome was successful for 55 (67.9%) patients and failed for 26 (32.1%). Successfully treated patients had a significant decrease of detrusor pressure, post-void residual volume, and bladder outlet obstruction index, as well as an increase in voiding efficiency at follow-up versus the treatment failure group. The logistic regression of urodynamic parameters and clinical variables revealed that a greater volume of first sensation of filling predicts a successful BoNT-A treatment outcome (p = 0.047). The urethral BoNT-A injection is effective in treating non-neurogenic women with DV, with a success rate of 67.9%. The videourodynamic characteristics of DV may differ among patients but does not affect the treatment outcome. |
format | Online Article Text |
id | pubmed-8159094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81590942021-05-28 Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women Jiang, Yuan-Hong Lee, Cheng-Ling Chen, Sheng-Fu Kuo, Hann-Chorng Toxins (Basel) Article Although female dysfunctional voiding (DV) is common in urological practice, it is difficult to treat. This study evaluated the therapeutic efficacy of urethral botulinum toxin A (BoNT-A) on non-neurogenic female DV. Based on the videourodynamic study (VUDS), the DV was classified into three subgroups according to the obstructive site. A successful treatment outcome was defined as an improvement of voiding efficiency by 10% and reported global response assessment by ≥1. The study compared therapeutic efficacy, baseline urodynamic parameters, and changes in urodynamic parameters between the treatment success and failure groups and among three DV subgroups. Predictive factors for successful treatment were also investigated. A total of 81 women with DV were categorized into three groups: 55 (67.9%) had mid-urethral DV, 19 (23.5%) had distal urethral DV, and 7 (8.6%) had combined BN dysfunction and mid-urethral DV after BN transurethral incision. The treatment outcome was successful for 55 (67.9%) patients and failed for 26 (32.1%). Successfully treated patients had a significant decrease of detrusor pressure, post-void residual volume, and bladder outlet obstruction index, as well as an increase in voiding efficiency at follow-up versus the treatment failure group. The logistic regression of urodynamic parameters and clinical variables revealed that a greater volume of first sensation of filling predicts a successful BoNT-A treatment outcome (p = 0.047). The urethral BoNT-A injection is effective in treating non-neurogenic women with DV, with a success rate of 67.9%. The videourodynamic characteristics of DV may differ among patients but does not affect the treatment outcome. MDPI 2021-05-19 /pmc/articles/PMC8159094/ /pubmed/34069448 http://dx.doi.org/10.3390/toxins13050362 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jiang, Yuan-Hong Lee, Cheng-Ling Chen, Sheng-Fu Kuo, Hann-Chorng Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title | Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title_full | Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title_fullStr | Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title_full_unstemmed | Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title_short | Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women |
title_sort | therapeutic effects of urethral sphincter botulinum toxin a injection on dysfunctional voiding with different videourodynamic characteristics in non-neurogenic women |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159094/ https://www.ncbi.nlm.nih.gov/pubmed/34069448 http://dx.doi.org/10.3390/toxins13050362 |
work_keys_str_mv | AT jiangyuanhong therapeuticeffectsofurethralsphincterbotulinumtoxinainjectionondysfunctionalvoidingwithdifferentvideourodynamiccharacteristicsinnonneurogenicwomen AT leechengling therapeuticeffectsofurethralsphincterbotulinumtoxinainjectionondysfunctionalvoidingwithdifferentvideourodynamiccharacteristicsinnonneurogenicwomen AT chenshengfu therapeuticeffectsofurethralsphincterbotulinumtoxinainjectionondysfunctionalvoidingwithdifferentvideourodynamiccharacteristicsinnonneurogenicwomen AT kuohannchorng therapeuticeffectsofurethralsphincterbotulinumtoxinainjectionondysfunctionalvoidingwithdifferentvideourodynamiccharacteristicsinnonneurogenicwomen |